Percentage of eosinophils with surface CD44 and levels of eosinophil cationic protein in the peripheral blood in children with bronchial asthma and their changes after montelukast therapy

Allergy and Asthma Proceedings

Volumn 27, Issue 4, 2006, Pages 378-382

  Kopřiva, František ^a,b   Szotkowská, Jarmila ^a,b   Ordeltová, Marta ^a,b   Zápalka, Martin ^a,b  

^a Palacky University ^*

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; EOSINOPHIL CATIONIC PROTEIN; HERMES ANTIGEN; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; QUINOLINE DERIVATIVE; RNASE3 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; ASTHMA; BLOOD; CHILD; DRUG ADMINISTRATION; EOSINOPHIL; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MALE; PRESCHOOL CHILD;

ACETATES; ADOLESCENT; ANTIGENS, CD44; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; LEUKOTRIENE ANTAGONISTS; MALE; QUINOLINES;

EID: 33748094422     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2902     Document Type: Article

References (23)

1. Holgate ST. Epithelial damage and response. Clin Exp Allergy 30(suppl 1):37-41, 2000.
2. Grebski E, Wu J, Wuthrich B, et al. Does eosinophil cationic protein in sputum and blood reflect bronchial inflammation and obstructive in allergic asthmaticd? Invest Allergol Clin Immunol 9:82-88, 1999.
3. Pure E, and Cuff CA. A crucial role for CD44 in inflammation. Trends Immunol 7:213-221, 2001.
4. Rothenberg ME. CD44-A sticky target for asthma. J Clin Invest 111:1460-1462, 2003.
5. Sano K, Yamauchi K, Hoshi H, et al. CD44 expression on blood eosinophils is a novel marker of bronchial asthma. Int Arch Allergy 114(suppl 1):67-71, 1997.
6. Thurau AM, Schulz U, Wolf V, et al. Identification of eosinophils by flow cytometry. Cytometry 23:150-158, 1996.
7. Enokihara H, Koike T, Nakamura Y, et al. Identification of surface molecules on eosinophils and lymphocytes in blood from patients with eosinophilia. Int Arch Immunol 114(suppl 1):72-74, 1997.
8. Laitinen A, and Laitinen LA. Airway morphology: Epithelium/basement membrane. Am J Respir Crit Care Med 150:S14-S17, 1994.
9. Frieri M. Asthma concepts in the new millennium. Update in asthma pathophysiology. Allergy Asthma Proc 26:83-88, 2005.
10. Peroni DG, Djukanovic R, Bradding P, et al. Expression of CD44 and integrin in bronchial mucosa of normal and mildly asthmatic subjects. Eur Respir J 9:2236-2242, 1996.
11. Frieri M. Corticosteroid effects on cytokines and chemokines. Allergy Asthma Proc 20:147-159, 1999.
12. Isacke CM, and Yarwood H. The hyaluronan receptor CD44. J Biochem Cell Biol 34:718-721, 2002.
13. Hamann KJ, Dowling TL, Neeley SP, et al. Hyaluronic acid enhance cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol 154:4073-4080, 1995.
14. Hartnell A, Robinson DS, Kay AB, et al. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80:281-286, 1993.
15. Matsumoto K, Appiah-Pippim J, Schleimer RP, et al. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am Respir Cell Mol Biol 18:860-866, 1998.
16. Katoh S, Taniguchi H, Matsubara Y, et al. Overexpression of CD44 on alveolar eosinophils with high concentrations of soluble CD44 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia. Allergy 54:1286-1292, 1999.
17. Katoh S, Matsumoto N, Kawakita K, et al. A role for CD44 in antigen induced murine model of pulmonary eosinophilia. J Clin Incest 111:1563-1570, 2003.
18. Sakamoto S, Oki K, Takahashi H, et al. Comparison of surface antigens on eosinophils from patients with eosinophilia. Int Arch Allergy Immunol 111(suppl 1):26-28, 1996.
19. Frieri M, Bennuri B, Diaz C, et al. Association between CD62 ligand and naive and memory T cells and a history of cow's milk allergy in atopic patients. Ann Allergy Asthma Immunol 92:562-572, 2004.
20. Kleinau I, Niggeman B, and Wahn U. Individual time-course of ECP and EPX during allergen provocation tests in asthmatic children. Pediatr Allergy Immunol 6:109-118, 1995.
21. Zápalka M, Kopriva F, and Szotkowská J. Eosinophilic cationic protein. Alergie 4:204-208, 1999.
22. Frieri M. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma. Allergy Asthma Proc 24:359-366, 2003.
23. Borish L. The role of leukotrienes in upper and košer airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 88(suppl 1):16-22, 2002.